|
RNF217 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.1538326677728E-14 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.10862446895044E-15 |
| Normal-vs-Stage2 |
2.765300E-04 |
| Normal-vs-Stage3 |
9.52219999517112E-08 |
| Normal-vs-Stage4 |
4.845800E-04 |
| Stage1-vs-Stage2 |
2.086000E-01 |
| Stage1-vs-Stage3 |
1.394570E-01 |
| Stage1-vs-Stage4 |
8.500700E-03 |
| Stage2-vs-Stage3 |
8.709800E-01 |
| Stage2-vs-Stage4 |
3.710800E-01 |
| Stage3-vs-Stage4 |
2.042800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.66133773404908E-12 |
| Normal-vs-AfricanAmerican |
1.102140E-03 |
| Normal-vs-Asian |
1.178300E-02 |
| Caucasian-vs-AfricanAmerican |
3.773200E-01 |
| Caucasian-vs-Asian |
6.059800E-02 |
| AfricanAmerican-vs-Asian |
4.504400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.42830208666101E-11 |
| Normal-vs-Female |
4.85167461761193E-14 |
| Male-vs-Female |
6.176500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.922000E-03 |
| Normal-vs-Age(41-60Yrs) |
1.0547118733939E-13 |
| Normal-vs-Age(61-80Yrs) |
3.89229981578865E-10 |
| Normal-vs-Age(81-100Yrs) |
4.526300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.179400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.212400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.388800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.968100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.326600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.026800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.570200E-04 |
| Normal-vs-Grade 2 |
1.62903024403249E-12 |
| Normal-vs-Grade 3 |
4.33650004794117E-09 |
| Normal-vs-Grade 4 |
1.218430E-03 |
| Grade 1-vs-Grade 2 |
1.497440E-01 |
| Grade 1-vs-Grade 3 |
2.600000E-02 |
| Grade 1-vs-Grade 4 |
8.398000E-03 |
| Grade 2-vs-Grade 3 |
3.361500E-02 |
| Grade 2-vs-Grade 4 |
1.062010E-02 |
| Grade 3-vs-Grade 4 |
3.013800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.62647673107585E-12 |
| Normal-vs-ccB subtype |
2.03389971531465E-10 |
| ccA subtype-vs-ccB subtype |
2.024800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.63502544836547E-12 |
| Normal-vs-N1 |
4.164600E-01 |
| N0-vs-N1 |
4.577600E-02 |
|
|
